𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PRO-PROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE9 (PCSK9) VARIANT DATABASE: PRELIMINARY ANALYSIS

✍ Scribed by S.E. Leigh; T. Jakubcova; R.A. Whittall; S.E. Humphries


Book ID
118422784
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
54 KB
Volume
207
Category
Article
ISSN
0021-9150

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Proprotein convertase subtilisin/kexin t
✍ Hong Lan; Ling Pang; Marsha M. Smith; Diane Levitan; Wei Ding; Li Liu; Lixin Sha 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB

## Abstract Proprotein convertase subtilisin/kexin type 9 (PCSK9) induces degradation of low‐density lipoprotein receptor (LDLR) in the liver. It is being pursued as a therapeutic target for LDL‐cholesterol reduction. Earlier genome‐wide gene expression studies showed that PCSK9 over‐expression in

New hypotheses about the structure–funct
✍ Robert A. Pearlstein; Qi-Ying Hu; Jing Zhou; David Yowe; Julian Levell; Bethany 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

## Abstract LDL cholesterol (LDL‐C) is cleared from plasma via cellular uptake and internalization processes that are largely mediated by the low‐density lipoprotein cholesterol receptor (LDL‐R). LDL‐R is targeted for lysosomal degradation by association with proprotein convertase subtilisin‐kexin